GREENBERG LON R

Director at UGI CORP /PA/ · on record since Jan 4, 2006
Director at Essential Utilities, Inc. · on record since Jun 5, 2006
Director at RespireRx Pharmaceuticals Inc. · on record since Jan 17, 2024
Director at AMERIGAS PARTNERS LP · on record since Mar 17, 2008
Chairman & Director at AMERIGAS PARTNERS LP · on record since May 20, 2010
Director at AMERIPRISE FINANCIAL INC · on record since Jun 17, 2011
Director at Cencora, Inc. · on record since May 20, 2013
Chairman & CEO at UGI CORP /PA/ · on record since May 16, 2005

Insider trading activity of GREENBERG LON R

Transactions on record: 281; since Jan 22, 2004

Open-market buys: 12; $1.6M

Open-market sells: 56; $78M

Companies traded: 6; last filing Sep 17, 2026

Figures computed from official regulatory filings — .

Companies where GREENBERG LON R has traded

Cencora, Inc.22 tx · $1.4M · Sep 17, 2026
RespireRx Pharmaceuticals Inc.7 tx · $1.3M · Mar 9, 2026
AMERIPRISE FINANCIAL INC15 tx · $448.4K · Apr 29, 2022
Essential Utilities, Inc.19 tx · $685.4K · Oct 5, 2017
UGI CORP /PA/211 tx · $219.5M · Jan 22, 2016
AMERIGAS PARTNERS LP7 tx · $447.5K · Dec 23, 2015

Track record of GREENBERG LON R

Statistical track record

Free

Open-market buys: 12

Last buy: Aug 9, 2016

Win rates and median returns are available with a free account (5 insiders/month).

Transaction history of GREENBERG LON R

Co-insiders of GREENBERG LON R

This page republishes public regulatory disclosures.

Company	Filed	Type	Qty	Price	Value · USD	Src
Cencora, Inc.Listing on record	Sep 17, 2026	Sell	-1,280	321.30 USD	$411.3K	SEC
RespireRx Pharmaceuticals Inc.Listing unverified	Mar 9, 2026	Award	557	359.28 USD	$200.1K	SEC
RespireRx Pharmaceuticals Inc.Listing unverified	May 16, 2025	Sell	-3,000	279.05 USD	$837.2K	SEC
RespireRx Pharmaceuticals Inc.Listing unverified	Mar 10, 2025	Award	789	—	—	SEC
RespireRx Pharmaceuticals Inc.Listing unverified	Aug 7, 2024	Gift	-5,000	0.00 USD	—	SEC
RespireRx Pharmaceuticals Inc.Listing unverified	May 10, 2024	Gift	-2,000	0.00 USD	—	SEC
RespireRx Pharmaceuticals Inc.Listing unverified	Mar 13, 2024	Award	843	—	—	SEC
RespireRx Pharmaceuticals Inc.Listing unverified	Jan 17, 2024	Exercise	1,340	219.43 USD	$294K	SEC
Cencora, Inc.Listing on record	Mar 13, 2023	Award	1,334	—	—	SEC
Cencora, Inc.Listing on record	Jan 18, 2023	Exercise	1,360	—	—	SEC
Cencora, Inc.Listing on record	Jan 18, 2023	ExerciseD (derivative)	-1,360	—	—	SEC
AMERIPRISE FINANCIAL INCListing on record	Apr 29, 2022	AwardD (derivative)	713.72	0.00 USD	—	SEC
Cencora, Inc.Listing on record	Mar 14, 2022	AwardD (derivative)	1,197	—	—	SEC
Cencora, Inc.Listing on record	Jan 19, 2022	ExerciseD (derivative)	-1,417	—	—	SEC
Cencora, Inc.Listing on record	Jan 19, 2022	Exercise	1,417	—	—	SEC
AMERIPRISE FINANCIAL INCListing on record	Sep 24, 2021	Gift	-2,500	0.00 USD	—	SEC
AMERIPRISE FINANCIAL INCListing on record	Apr 30, 2021	AwardD (derivative)	584.52	0.00 USD	—	SEC
Cencora, Inc.Listing on record	Mar 12, 2021	AwardD (derivative)	1,593	—	—	SEC
Cencora, Inc.Listing on record	Jan 15, 2021	ExerciseD (derivative)	-1,206	—	—	SEC
Cencora, Inc.Listing on record	Jan 15, 2021	Exercise	1,206	—	—	SEC
AMERIPRISE FINANCIAL INCListing on record	May 1, 2020	AwardD (derivative)	1,270.97	0.00 USD	—	SEC
Cencora, Inc.Listing on record	Mar 6, 2020	AwardD (derivative)	2,012	0.00 USD	—	SEC
AMERIPRISE FINANCIAL INCListing on record	Apr 26, 2019	AwardD (derivative)	1,041.67	0.00 USD	—	SEC
Cencora, Inc.Listing on record	Mar 1, 2019	AwardD (derivative)	2,101	83.30 USD	$175K	SEC
AMERIPRISE FINANCIAL INCListing on record	Apr 27, 2018	AwardD (derivative)	1,060.52	0.00 USD	—	SEC

Company	Filed	Type	Qty	Price	Value · USD	Src
Cencora, Inc.Listing on record	Sep 17, 2026	Sell	-1,280	321.30 USD	$411.3K	SEC
RespireRx Pharmaceuticals Inc.Listing unverified	Mar 9, 2026	Award	557	359.28 USD	$200.1K	SEC
RespireRx Pharmaceuticals Inc.Listing unverified	May 16, 2025	Sell	-3,000	279.05 USD	$837.2K	SEC
RespireRx Pharmaceuticals Inc.Listing unverified	Mar 10, 2025	Award	789	—	—	SEC
RespireRx Pharmaceuticals Inc.Listing unverified	Aug 7, 2024	Gift	-5,000	0.00 USD	—	SEC
RespireRx Pharmaceuticals Inc.Listing unverified	May 10, 2024	Gift	-2,000	0.00 USD	—	SEC
RespireRx Pharmaceuticals Inc.Listing unverified	Mar 13, 2024	Award	843	—	—	SEC
RespireRx Pharmaceuticals Inc.Listing unverified	Jan 17, 2024	Exercise	1,340	219.43 USD	$294K	SEC
Cencora, Inc.Listing on record	Mar 13, 2023	Award	1,334	—	—	SEC
Cencora, Inc.Listing on record	Jan 18, 2023	Exercise	1,360	—	—	SEC
Cencora, Inc.Listing on record	Jan 18, 2023	ExerciseD (derivative)	-1,360	—	—	SEC
AMERIPRISE FINANCIAL INCListing on record	Apr 29, 2022	AwardD (derivative)	713.72	0.00 USD	—	SEC
Cencora, Inc.Listing on record	Mar 14, 2022	AwardD (derivative)	1,197	—	—	SEC
Cencora, Inc.Listing on record	Jan 19, 2022	ExerciseD (derivative)	-1,417	—	—	SEC
Cencora, Inc.Listing on record	Jan 19, 2022	Exercise	1,417	—	—	SEC
AMERIPRISE FINANCIAL INCListing on record	Sep 24, 2021	Gift	-2,500	0.00 USD	—	SEC
AMERIPRISE FINANCIAL INCListing on record	Apr 30, 2021	AwardD (derivative)	584.52	0.00 USD	—	SEC
Cencora, Inc.Listing on record	Mar 12, 2021	AwardD (derivative)	1,593	—	—	SEC
Cencora, Inc.Listing on record	Jan 15, 2021	ExerciseD (derivative)	-1,206	—	—	SEC
Cencora, Inc.Listing on record	Jan 15, 2021	Exercise	1,206	—	—	SEC
AMERIPRISE FINANCIAL INCListing on record	May 1, 2020	AwardD (derivative)	1,270.97	0.00 USD	—	SEC
Cencora, Inc.Listing on record	Mar 6, 2020	AwardD (derivative)	2,012	0.00 USD	—	SEC
AMERIPRISE FINANCIAL INCListing on record	Apr 26, 2019	AwardD (derivative)	1,041.67	0.00 USD	—	SEC
Cencora, Inc.Listing on record	Mar 1, 2019	AwardD (derivative)	2,101	83.30 USD	$175K	SEC
AMERIPRISE FINANCIAL INCListing on record	Apr 27, 2018	AwardD (derivative)	1,060.52	0.00 USD	—	SEC